Pain often accompanies antigen-specific immune-related disorders though little is known of the underlying neural mechanisms. A common feature among these disorders is the elevated level of antigenspecific immunoglobulin (Ig) G in the serum and the presence of IgG immune complex (IC) in the affected tissue. We hypothesize that IC may directly activate the Fc-gamma receptor type I (FccRI) expressed in nociceptive dorsal root ganglion (DRG) neurons and increase neuronal excitability thus potentially contributing to pain. Immunofluorescent labeling indicated that FccRI, but not FccRIIB or FccRIII, was expressed in a subpopulation of rat DRG neurons including those expressing nociceptive markers. Calcium imaging revealed that the IC, but neither of the antibody (IgG) or antigen alone, produced an increase in intracellular calcium. This effect was abolished by the removal of the IgG Fc portion in the IC or the application of an anti-FccRI antibody, suggesting a key role of the FccRI receptor. Removal of extracellular calcium or depletion of intracellular calcium stores prevented the IC-induced calcium response. In whole-cell current-clamp recordings, IC depolarized the resting membrane potential, decreased the rheobase, and increased the number of action potentials evoked by a depolarizing current at 2Â rheobase. In about half of the responsive neurons, IC evoked action potential discharges. These results suggest that a subpopulation of nociceptive neurons expresses functional FccRI and that the activation of this receptor by IC increases neuronal excitability.
Introduction
Pain often accompanies antigen-specific immune-related disorders that include autoimmune diseases such as Guillain-Barre Syndrome (Moulin, 1998; Moulin et al., 1997) and multiple sclerosis (Kenner et al., 2007) , allergic diseases such as atopic and allergic contact dermatitis (Valks and Conde-Salazar, 2003; Wittkowski et al., 2007) , and infectious diseases such as herpes zoster (Oaklander, 2008) . However, there is insufficient information about the underlying neuronal mechanisms by which an antigen might act to produce pain. A common feature of these diseases is the elevated level of antigen-specific immunoglobulins (Ig), especially IgG in the serum and the presence of immune complex (IC) formed by IgG bound to an antigen (IgG-IC) in the affected tissue (Ferguson and Salinas, 1984; Haanpaa et al., 1998; Stinissen et al., 1997; Yuki et al., 1992) .
Fc-gamma receptor (FccR) is the receptor that binds to the Fc portion of IgG. FccRs are typically expressed on immune cells. There are two functionally different classes of FccRs: the activating and inhibitory receptors (Nimmerjahn and Ravetch, 2006, 2008) . The activation of FccR by IgG-IC triggers a wide range of biological functions including phagocytosis, antibody-dependent cell-mediated cytotoxicity and the release of cytokines (Nimmerjahn and Ravetch, 2008) . FccR type I (FccRI) is the only high-affinity activating receptor, and has been found critically involved in a number of inflammatory and immune responses (Barnes et al., 2002; IoanFacsinay et al., 2002) including certain immune-related disorders in the central nervous system (Okun et al., 2010) . Treatments such as intravenous immunoglobulin that potentially block FccRI or reduce the IgG-IC were found to ameliorate symptoms, including pain, in a number of immune-related diseases such as multiple sclerosis (Humle Jorgensen and Sorensen, 2005) , systemic lupus erythematosus (Zandman-Goddard et al., 2009 ) and complex regional syndromes (Goebel et al., 2010) .
IC induced cutaneous hyperalgesia after the injection of a foreign antigen to the hind paw of mice (Verri et al., 2008) and rats (Ma et al., 2009) immunized with the same antigen and exhibiting an elevated level of serum IgG. Although it is well known that IgG-IC may induce pain and hyperalgesia via the activation of certain immune cells and the release of pro-inflammatory cytokines (Pinto et al., 2010; Verri et al., 2007 Verri et al., , 2008 , a direct effect of the IgG-IC on the excitability of nociceptive primary sensory neurons has not been determined. As suggested in a previous report by Andoh
